$Akari Therapeutics(AKTX.US)$Exhibit 99.1 Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merger Entity •Prioritization of Peak’s ADC cancer therapeutic platform technology and Akari’s PAS-nomacopan for Geographic Atrophy, a disabling ophthalmic disease•Akari Therapeutics announces leadership changes in separate Akari press release BOSTON and PLEASANTON, May 1, 2024 (GLOBE NEWSWIRE) - Akari Therapeutics, Plc ...
$Akari Therapeutics(AKTX.US)$Akari Therapeutics to Present PAS-Nomacopan Pre-Clinical Electroretinography (ERG) Data at ARVO 2024 MAY 5th! 8 MINUTES AGO, 8:00 AM EDT VIA GLOBENEWSWIRE
$Akari Therapeutics(AKTX.US)$Price can go down more. But from a RSI standpoint point, she be low low! Hehehe! RSI 7 = 11.30! RSI 14 = 18.15! Talk about OS! Hehehe! And a bit of a kicker. This is a piece of the 8K filed on 4/1/24! Could end up being the catalyst that im looking for? Being honest i missed the price drop to 1.19 ( 52wk low ) to start scaling in! Grrrrrr! Hehehe! But im still fixing to start scaling in! And im approaching this as a longer term swing as ...
$Akari Therapeutics(AKTX.US)$Just off ATL! And you know i loves me the bottoms! Hehehe! Severly OS on the daily! RSI 7 = 15.05 RSI 14 = 25.19! And the chart is trying to show a reversal could be coming if just some volume shows up!
Dr. Patel's appointment to Akari's Board of Directors is seen as favorable due to his broad experience in life sciences and entrepreneurship. His leadership could be key in Akari realizing the potential of their main asset, nomacopan.
Akari Therapeutics股票討論區
Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merger Entity
•Prioritization of Peak’s ADC cancer therapeutic platform technology and Akari’s PAS-nomacopan for Geographic Atrophy, a disabling ophthalmic disease•Akari Therapeutics announces leadership changes in separate Akari press release
BOSTON and PLEASANTON, May 1, 2024 (GLOBE NEWSWIRE) - Akari Therapeutics, Plc ...
8 MINUTES AGO, 8:00 AM EDT
VIA GLOBENEWSWIRE
暫無評論